Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 May 2006

Hwang Rudi, Shinkai Takahiro, Deluca Vincenzo, Macciardi Fabio, Potkin Steven, Meltzer Herbert Y, Kennedy James L

Abstract excerpt

OBJECTIVE: Explore relationships between 12 dopamine D2 gene variants and quantitative measures of positive and negative symptom response following clozapine treatment in two treatment refractory or intolerant populations (Caucasian and African-American). EXPERIMENTAL PROCEDURES: Subjects included 97 Caucasian and 35 African-American DSM-III-R or DSM-IV schizophrenics and were genotyped by 5'-exonuclease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clozapine

Share to Demography

Share to Psychiatric Status Rating Scales

Share to Receptors, Dopamine D2

Share to Schizophrenia

Share to White People

Source

Identifiers

PMID: 16278074
DOI: 10.1016/j.euroneuro.2005.09.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.PMID 16278074Read ↗

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.Semantic proximity Read ↗

Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.Semantic proximity Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.Semantic proximity Read ↗

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.Semantic proximity Read ↗

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.Semantic proximity Read ↗

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.Semantic proximity Read ↗

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.Semantic proximity Read ↗

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant SchizophreniaSemantic proximity Read ↗

Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine responseSemantic proximity Read ↗

Association between clozapine response and allelic variation in 5-HT2A receptor gene.Semantic proximity Read ↗

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.